Risk Assessment in Myelofibrosis
Вставка
- Опубліковано 27 лют 2019
- Physician Assistant Amber Essenmacher PA-C, MMS specializes in helping people with rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). She describes tools that healthcare teams use to help assess and classify risk levels in myelofibrosis (MF). She reviews scoring tools known as the IPSS, DIPSS, and DIPSS Plus. They help healthcare teams classify MF as low-risk, intermediate-risk, or high-risk. They also help determine how a patient’s disease may change over time.
To learn more about tracking a variety of factors related to MF, visit www.voicesofmp....
Sponsored by Incyte Corporation.
© 2019, Incyte Corporation. MAT-HEM-00528 02/19
